Blood-biomarkers and devices for atrial fibrillation screening: Lessons learned from the AFRICAT (Atrial Fibrillation Research In CATalonia) study.
Elena PalàAlejandro BustamanteJosep Lluis Clúa-EspunyJuan AcostaFelipe González-LoyolaSara Dos SantosDomingo Ribas-SeguiJosep Lluís Clua-EspunyAnna PenalbaMarina GiraltIñigo Lechuga-DuranDelicia Gentille-LorenteAlonso PedroteMiguel-Ángel MuñozJoan MontanerPublished in: PloS one (2022)
The inclusion and monitoring of a cohort of primary care patients for AF detection, together with the testing of biomarkers and screening devices provided useful lessons about AF screening in our community. An AF screening strategy using rhythm detection devices and short monitoring periods among high-risk patients with high NT-proBNP levels could be feasible.
Keyphrases
- atrial fibrillation
- primary care
- oral anticoagulants
- catheter ablation
- left atrial
- direct oral anticoagulants
- left atrial appendage
- heart failure
- end stage renal disease
- percutaneous coronary intervention
- mental health
- chronic kidney disease
- blood pressure
- label free
- prognostic factors
- left ventricular
- peritoneal dialysis
- mitral valve
- heart rate
- general practice